These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 33507625)

  • 1. Unveiling the Potential of Transition Metal Complexes for Medicine: Translational in Situ Activation of Metal-Based Drugs from Bench to in Vivo Applications.
    Silva MJSA; Gois PMP; Gasser G
    Chembiochem; 2021 May; 22(10):1740-1742. PubMed ID: 33507625
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Porphyrin complexes of the period 6 main group and late transition metals.
    Lemon CM; Brothers PJ; Boitrel B
    Dalton Trans; 2011 Jul; 40(25):6591-609. PubMed ID: 21384031
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bioorthogonal Activation of Dual Catalytic and Anti-Cancer Activities of Organogold(I) Complexes in Living Systems.
    Long Y; Cao B; Xiong X; Chan ASC; Sun RW; Zou T
    Angew Chem Int Ed Engl; 2021 Feb; 60(8):4133-4141. PubMed ID: 33151608
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent Advances and Therapeutic Journey of Schiff Base Complexes with Selected Metals (Pt, Pd, Ag, Au) as Potent Anticancer Agents: A Review.
    Khan S; Alhumaydhi FA; Ibrahim MM; Alqahtani A; Alshamrani M; Alruwaili AS; Hassanian AA; Khan S
    Anticancer Agents Med Chem; 2022; 22(18):3086-3096. PubMed ID: 35546764
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platinum, palladium, gold and ruthenium complexes as anticancer agents: Current clinical uses, cytotoxicity studies and future perspectives.
    Lazarević T; Rilak A; Bugarčić ŽD
    Eur J Med Chem; 2017 Dec; 142():8-31. PubMed ID: 28442170
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metal N-heterocyclic carbene complexes as potential antitumor metallodrugs.
    Liu W; Gust R
    Chem Soc Rev; 2013 Jan; 42(2):755-73. PubMed ID: 23147001
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Azaindoles: Suitable ligands of cytotoxic transition metal complexes.
    Štarha P; Trávníček Z
    J Inorg Biochem; 2019 Aug; 197():110695. PubMed ID: 31054487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent development of transition metal complexes with in vivo antitumor activity.
    Liang JX; Zhong HJ; Yang G; Vellaisamy K; Ma DL; Leung CH
    J Inorg Biochem; 2017 Dec; 177():276-286. PubMed ID: 28641893
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mitochondria as a target of third row transition metal-based anticancer complexes.
    Olelewe C; Awuah SG
    Curr Opin Chem Biol; 2023 Feb; 72():102235. PubMed ID: 36516614
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Noble metal-dithiocarbamates precious allies in the fight against cancer.
    Nagy EM; Ronconi L; Nardon C; Fregona D
    Mini Rev Med Chem; 2012 Oct; 12(12):1216-29. PubMed ID: 22931593
    [TBL] [Abstract][Full Text] [Related]  

  • 11. "Good Fashion is Evolution, Not Revolution" - Methods to Enhance Existing Anticancer Medicines, Primarily with the Use of Transition Metal.
    Guzowska M; Kalinowska M; Lewandowski W
    Anticancer Agents Med Chem; 2018; 18(4):476-487. PubMed ID: 29189181
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent development of gold(I) and gold(III) complexes as therapeutic agents for cancer diseases.
    Lu Y; Ma X; Chang X; Liang Z; Lv L; Shan M; Lu Q; Wen Z; Gust R; Liu W
    Chem Soc Rev; 2022 Jul; 51(13):5518-5556. PubMed ID: 35699475
    [TBL] [Abstract][Full Text] [Related]  

  • 13. N-heterocyclic carbene metal complexes as bio-organometallic antimicrobial and anticancer drugs.
    Patil SA; Patil SA; Patil R; Keri RS; Budagumpi S; Balakrishna GR; Tacke M
    Future Med Chem; 2015; 7(10):1305-33. PubMed ID: 26144266
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metal-containing drugs and novel coordination complexes in therapeutic anticancer applications--part II.
    Kostova I
    Anticancer Agents Med Chem; 2010 Jun; 10(5):352-3. PubMed ID: 20545617
    [No Abstract]   [Full Text] [Related]  

  • 15. Anticancer Metallocenes and Metal Complexes of Transition Elements from Groups 4 to 7.
    Kostova I
    Molecules; 2024 Feb; 29(4):. PubMed ID: 38398576
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular Design of Bioorthogonal Probes and Imaging Reagents Derived from Photofunctional Transition Metal Complexes.
    Lo KK
    Acc Chem Res; 2020 Jan; 53(1):32-44. PubMed ID: 31916746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclometalated Palladium(II) N-Heterocyclic Carbene Complexes: Anticancer Agents for Potent In Vitro Cytotoxicity and In Vivo Tumor Growth Suppression.
    Fong TT; Lok CN; Chung CY; Fung YM; Chow PK; Wan PK; Che CM
    Angew Chem Int Ed Engl; 2016 Sep; 55(39):11935-9. PubMed ID: 27571430
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transition metal chelators, pro-chelators, and ionophores as small molecule cancer chemotherapeutic agents.
    Steinbrueck A; Sedgwick AC; Brewster JT; Yan KC; Shang Y; Knoll DM; Vargas-Zúñiga GI; He XP; Tian H; Sessler JL
    Chem Soc Rev; 2020 Jun; 49(12):3726-3747. PubMed ID: 32525153
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fighting Cancer with Transition Metal Complexes: From Naked DNA to Protein and Chromatin Targeting Strategies.
    Palermo G; Magistrato A; Riedel T; von Erlach T; Davey CA; Dyson PJ; Rothlisberger U
    ChemMedChem; 2016 Jun; 11(12):1199-210. PubMed ID: 26634638
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent researches in metal supramolecular complexes as anticancer agents.
    Zhou CH; Zhang YY; Yan CY; Wan K; Gan LL; Shi Y
    Anticancer Agents Med Chem; 2010 Jun; 10(5):371-95. PubMed ID: 20380632
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.